SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A BCDE FGHIJ KLMN OPQR STUV WXYZ

Browse current Australian managed funds

0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

POLYNOVO LIMITED (PNV)

Listed on ASX

SHARE PRICES

(updated weekly)

Former (or subsequent) names

 FROMTO
POLYNOVO LIMITED01/12/2014
CALZADA LIMITED01/12/200901/12/2014
METABOLIC PHARMACEUTICALS LIMITED01/12/2009

Shareholder links

Our website ranking of PNV: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Unit 2, 320 Lorimer Street, PORT MELBOURNE, VIC, AUSTRALIA, 3207
Tel:  (03) 8681 4050 Fax: (03) 8681 4099

Date first listed: 26/11/1998
Company Secretary: Jan-Marcel Gielen
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: PolyNovo develops and commercialises innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy

name changed from Calzada Limited

01/12/2014

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    27/05/2020David McQuillan-441,687$2.680$1,183,721
    30/03/2020David Williams100,000$1.540$154,000
    23/03/2020David Williams100,000$1.400$140,000
    17/03/2020David Williams100,000$1.475$147,500
    10/03/2020David McQuillan50,000$1.900$95,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David WilliamsNon Exec Chairman28/02/2014
    Paul BrennanManaging Director13/11/2014
    Ashok SrinivasanCOO06/05/2019
    Jan-Marcel GielenCFO10/12/2018
    David McQuillanIndependent Director08/08/2012
    Philip PowellIndependent Director14/05/2014
    Robyn ElliottNon Exec Director28/10/2019
    Leon HoareNon Exec Director27/01/2016
    Christine EmmanuelNon Exec Director13/05/2020
    Max JohnstonNon Exec Director14/05/2014
    Bruce RathieNon Exec Director18/02/2010

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Greg LewisCFO, COO24/01/201807/12/2018
    Gavin SmithCFO06/02/201724/01/2018
    Andrea GoldieCFO27/10/201506/02/2017
    Christopher MewsCFO01/09/200927/10/2015
    Roger AstonNon Exec Director15/11/201310/09/2014
    David FranklynNon Exec Director20/04/200915/11/2013
    John ChiplinNon Exec Director18/10/201013/11/2012

    Date of first appointment, title may have changed.